Hui Qin

Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Peritoneal effusion as a marker of disease severity in secondary hemophagocytic lymphohistiocytosis: Clinical and immunological insights.

Peritoneal effusion as a marker of disease severity in secondary hemophagocytic lymphohistiocytosis: Clinical and immunological insights.

Journal: SAGE open medicine

Published: May 31, 2026

Application of DeepSeek-assisted problem-based learning in hematology residency training.

Application of DeepSeek-assisted problem-based learning in hematology residency training.

Journal: BMC medical education

Published: May 09, 2025

Identification and construction of a novel NET-related gene signature for predicting prognosis in multiple myeloma.

Identification and construction of a novel NET-related gene signature for predicting prognosis in multiple myeloma.

Journal: Clinical and experimental medicine

Published: January 14, 2025

Single-cell RNA Sequencing Identifies Prognostic Biomarkers in Extramedullary Multiple Myeloma.

Single-cell RNA Sequencing Identifies Prognostic Biomarkers in Extramedullary Multiple Myeloma.

Journal: Current medicinal chemistry

Published: September 19, 2024

Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors

Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 25, 2023

Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia.

Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia.

Journal: Annals of hematology

Published: January 03, 2023

A Real-World Study of the Effect of rhG-CSF on Clinical Efficacy and Flow Cytometry MRD after Initial Induction Therapy for Acute Myeloid Leukemia

A Real-World Study of the Effect of rhG-CSF on Clinical Efficacy and Flow Cytometry MRD after Initial Induction Therapy for Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 18, 2022

Identification of biomarkers for early diagnosis of multiple myeloma by weighted gene co-expression network analysis and their clinical relevance.

Identification of biomarkers for early diagnosis of multiple myeloma by weighted gene co-expression network analysis and their clinical relevance.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 01, 2022

Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia.

Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia.

Journal: Nature communications

Published: September 16, 2019

Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.

Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.

Journal: Leukemia research

Published: March 28, 2015

Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.

Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.

Journal: Cancer immunology, immunotherapy : CII

Published: June 15, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026